Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-10-04 Sale | 2021-10-05 9:05 pm | Allovir Inc. | ALVR | Melian Agustin Chief Medical Officer | 18,689 | $23.91 | $446,862 | 453,529 (Direct) | View |
| 2021-09-28 Sale | 2021-09-29 4:15 pm | Allovir Inc. | ALVR | Melian Agustin Chief Medical Officer | 3,750 | $24.12 | $90,432 | 472,218 (Direct) | View |
| 2021-04-05 Sale | 2021-09-20 4:05 pm | Allovir Inc. | ALVR | Melian Agustin Chief Medical Officer | 40,548 | $22.11 | $896,685 | 475,968 (Direct) | View |
| 2021-03-22 Sale | 2021-03-24 4:53 pm | Allovir Inc. | ALVR | Melian Agustin Chief Medical Officer | 3,750 | $25.97 | $97,394 | 516,516 (Direct) | View |
| 2021-02-02 Sale | 2021-02-04 4:35 pm | Allovir Inc. | ALVR | Melian Agustin Chief Medical Officer | 54,849 | $41.19 | $2,259,230 | 520,266 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-10-14 Disposition | 2022-10-14 4:06 pm | N/A N/A | Forma Therapeutics Holdings Inc. | FMTX | Melian Agustin EVP, Research & Development | 118,000 | $0 | 0 (Direct) | View |
| 2022-10-14 Equity Swap | 2022-10-14 4:06 pm | N/A N/A | Forma Therapeutics Holdings Inc. | FMTX | Melian Agustin EVP, Research & Development | 79,000 | $0 | 0 (Direct) | View |
| 2022-07-11 Option Award | 2022-07-12 4:24 pm | N/A 2032-07-10 | Forma Therapeutics Holdings Inc. | FMTX | Melian Agustin EVP, Research & Development | 197,000 | $0 | 197,000 (Direct) | View |
| 2021-01-19 Option Award | 2021-01-21 7:28 pm | N/A 2031-01-19 | Allovir Inc. | ALVR | Melian Agustin Chief Medical Officer | 125,000 | $0 | 656,365 (Direct) | View |
| 2020-07-29 Option Award | 2020-07-31 6:44 pm | N/A 2030-07-29 | Allovir Inc. | ALVR | Melian Agustin Chief Medical Officer | 220,700 | $0 | 220,700 (Direct) | View |
Ownership | 2020-07-30 08:16 am | N/A N/A | Allovir Inc. | ALVR | Melian Agustin Chief Medical Officer | 0 | $0 | 531,365 (Direct) | View |